CRBU - Caribou Biosciences, Inc.

QQQ na na (na)

DIA na na (na)

SPY na na (na)

TLT na na (na)

GLD na na (na)

Previous Close

$ na

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

na - na

Volume

Average Volume

Market Cap

Beta (5Y Monthly)

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na (na)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Cracking The Code: Understanding Analyst R...
06/04/2024 13:00:30

HC Wainwright & Co. Maintains Buy on Carib...
06/04/2024 10:13:37

HC Wainwright & Co. analyst Robert Burns maintains Caribou Biosciences (NASDAQ:CRBU) with a Buy and lowers the price tar...

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
06/03/2024 16:31:06

Caribou Biosciences Announced Clinical Da...
06/02/2024 23:59:39

attention-biotech-investors---stocks-to-watch-from-rbc-global-healthcare-conference

Attention Biotech Investors - Stocks To Wa...
05/16/2024 18:21:31

RBC's Chris McCarthy discusses biotech investor sentiment at the RBC Global Healthcare Conference. Focused on upcoming bina...

Expert Ratings For Caribou Biosciences
05/16/2024 18:01:25

Truist Securities Maintains Buy on Caribou...
05/16/2024 17:11:51

Truist Securities analyst Asthika Goonewardene maintains Caribou Biosciences (NASDAQ:CRBU) with a Buy and maintains $19 pric...

HC Wainwright & Co. Reiterates Buy on Cari...
05/13/2024 17:44:44

HC Wainwright & Co. analyst Robert Burns reiterates Caribou Biosciences (NASDAQ:CRBU) with a Buy and maintains $24 price...

Caribou Biosciences Q1 EPS $(0.46) Misses ...
05/07/2024 21:16:31

Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of...

Caribou Biosciences To Present Initial Dos...
04/24/2024 14:03:07

Caribou Biosciences, Inc. (NASDAQ:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announ...

Caribou Biosciences Announces Oral Present...
04/15/2024 13:15:04

Caribou Biosciences, Inc. (NASDAQ:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announ...

kura-sushi-posts-upbeat-sales-joins-caribou-biosciences-krispy-kreme-and-other-big-stocks-moving-higher-in-fridays-pre-market-session

Kura Sushi Posts Upbeat Sales, Joins Carib...
04/05/2024 12:01:39

U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Friday.

Caribou Biosciences Expands Clinical Devel...
04/04/2024 20:01:12

-- FDA has cleared Caribou's IND application for CB-010 in lupus nephritis and extrarenal lupus; GALLOP Phase 1 clinical tr...

HC Wainwright & Co. Maintains Buy on Carib...
03/19/2024 10:26:13

HC Wainwright & Co. analyst Robert Burns maintains Caribou Biosciences (NASDAQ:CRBU) with a Buy and raises the price tar...

investor-sentiment-improves-following-inflation-data-dow-jumps-over-200-points

Investor Sentiment Improves Following Infl...
03/13/2024 08:42:45

The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, but the index remained in the "...

gold-down-over-1-clearone-shares-spike-higher

Gold Down Over 1%; ClearOne Shares Spike H...
03/12/2024 18:57:39

U.S. stocks traded higher toward the end of trading, with the S&P 500 index gaining over 1% on Tuesday. The Dow traded up ...

Why Asana Shares Are Trading Lower By 11%?...
03/12/2024 18:07:31

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
03/12/2024 17:31:12

RBC Capital Reiterates Outperform on Carib...
03/12/2024 14:49:46

RBC Capital analyst Luca Issi reiterates Caribou Biosciences (NASDAQ:CRBU) with a Outperform and maintains $19 price target.

Caribou Biosciences Q4 EPS $(0.39) Misses ...
03/11/2024 20:22:20

Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of...

CLASS ACTION DEADLINES - JOIN NOW!

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)

07/15/2024 UnitedHealth Group Inc. (UNH)

07/16/2024 Teladoc Health, Inc. (TDOC)

07/16/2024 Vestis Corporation (VSTS)

07/22/2024 Cambium Networks Corporation (CMBM)

07/22/2024 Biogen Inc. (BIIB)

07/23/2024 Fastly, Inc. (FSLY)

07/29/2024 Enphase Energy, Inc. (ENPH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)

CRBUCaribou Biosciences, Inc.

Nasdaq cariboubio.com

na (na)